Letters15 May 1996Blood Donors with Antibody to Hepatitis C VirusA. Obaid Shakil, MD and Harvey J. Alter, MDA. Obaid Shakil, MDUniversity of Pittsburgh Medical Center; Pittsburgh, PA 15213-2582National Institutes of Health; Bethesda, MD 20892Search for more papers by this author and Harvey J. Alter, MDUniversity of Pittsburgh Medical Center; Pittsburgh, PA 15213-2582National Institutes of Health; Bethesda, MD 20892Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-124-10-199605150-00029 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail IN RESPONSE:Dr. Klein raises the issue of selection bias, arguing that persons with a defined risk factor for liver disease or those with symptoms were more likely to participate in our study. We agree that the characteristics of persons who declined to participate in the study would have been useful information for the reader. It is probable, however, that the bias could have gone in either direction and thus did not significantly affect our conclusions.Dr. Worman points to discrepancies between the results in our study and those in the study recently reported by Tong and colleagues [1]. We ...REFERENCE1. Tong MJ, El-Farra NS, Reikes AR, Co RL. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med. 1995; 332:1463-6. Google Scholar Author, Article, and Disclosure InformationAffiliations: University of Pittsburgh Medical Center; Pittsburgh, PA 15213-2582National Institutes of Health; Bethesda, MD 20892 PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics 15 May 1996Volume 124, Issue 10Page: 931KeywordsAntibody productionBlood donorsChronic hepatitis CHepatitis C virusLiver diseasesMedical risk factorsProgressive diseases Issue Published: 15 May 1996 CopyrightCopyright © 1996 by American College of Physicians. All Rights Reserved.PDF DownloadLoading ...